Evidence map›Paper›PMID 9518725›Full record

ArticleThe Journal of physiology1998

Protein kinases modulate two glycine currents in salamander retinal ganglion cells.

Y Han, M M Slaughter

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of physiology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A zinc-dependent Cl- current in neuronal somata.The Journal of neuroscience : the official journal of the Society for Neuroscience · 1999
    Article
  8. Modulation of glycine receptors in retinal ganglion cells by zinc.Proceedings of the National Academy of Sciences of the United States of America · 1999
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Y HanDepartments of Physiology & Biophysics and Ophthalmology, School of Medicine, State University of New York at Buffalo, 124 Sherman Hall, Buffalo, NY 14214, USA.
M M Slaughter
University at Buffalo, State University of New York · US

Funding

SYNAPTIC MECHANISMS IN THE VERTEBRATE RETINAR01EY005725 · NEI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SLAUGHTER, MALCOLM M · 1985 to 2012
$4.4M
NEI NIH HHS EY05725NEI NIH HHS R01 EY005725
6 · The paper itself

Abstract

1. Protein kinase modulation of glycine-activated currents was examined in acutely dissociated ganglion cells from tiger salamander retina using whole-cell voltage-clamp techniques. 2. Glycine (100 microM) induced an outward chloride current in cells clamped at 0 mV. Co-application of 50 microM forskolin made the glycine-induced current more transient. The combination of forskolin and glycine reduced the later portion of current response without changing the initial peak amplitude. 3. 3-Isobutyl-1-methylxanthine (IBMX) or 8-bromoadenosine 3',5'-cyclic monophosphate (8-Br-cAMP) produced effects similar to those of forskolin. H-89, a protein kinase A (PKA) inhibitor, blocked the effect of forskolin. 4. A protein kinase C (PKC) activator, OAG (1-oleoyl-2-acetyl-sn-glycerol), also made the glycine response more transient. Unlike PKA analogues, OAG enhanced the glycine peak response without changing the glycine late response. OAG effects were blocked by 1 microM GF-109203X, a PKC inhibitor. 5. Nanomolar concentrations of strychnine selectively blocked the fast phase of the glycine current and reversed the effect of OAG, but not that of forskolin. Conversely, forskolin occluded the effect of 5,7-dichlorokynurenic acid, which selectively suppresses the late phase of the glycine current. The action of OAG was not blocked by 5,7-dichlorokynurenic acid. 6. Thus, through a differential modulation, both protein kinase A and C shorten the decay time of the glycine current. PKA suppresses the slow component, while PKC potentiates the fast component.

Indexed as

Sulfonamides1-Methyl-3-isobutylxanthine8-Bromo Cyclic Adenosine MonophosphateAmbystomaAnimalsColforsinCyclic AMP-Dependent Protein KinasesEnzyme InhibitorsExcitatory Amino Acid AntagonistsGlycineGlycine AgentsIsoquinolinesKineticsKynurenic AcidMembrane PotentialsPatch-Clamp Techniques1-Methyl-3-isobutylxanthine5,7-dichlorokynurenic acid8-Bromo Cyclic Adenosine MonophosphateColforsinCyclic AMP-Dependent Protein KinasesEnzyme InhibitorsExcitatory Amino Acid AntagonistsGlycineGlycine AgentsIsoquinolinesKynurenic AcidN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamidePhosphodiesterase InhibitorsProtein Kinase CStrychnineSulfonamides

Identifiers

PMID9518725
PMCPMC2230902
OpenAlexW2002660309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.